# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $41.
Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and lowers the price target from $45 t...
JP Morgan analyst Michael Mueller maintains Lineage (NASDAQ:LINE) with a Underweight and lowers the price target from $44 to...
Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:LINE) with a Equal-Weight and lowers the price target from $5...
Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and raises the price target from $43 t...
Barclays analyst Brendan Lynch maintains Lineage (NASDAQ:LINE) with a Overweight and lowers the price target from $52 to $51.
Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and lowers the price target from $50 t...
Scotiabank analyst Greg McGinniss maintains Lineage (NASDAQ:LINE) with a Sector Perform and lowers the price target from $49...